Loading clinical trials...

Detection of Viral Particels in Urticaria Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03151902

Detection of Viral Particels in Urticaria Patients

Blood samples from urticaria patients will be analyzed for viral particles

Lead sponsor: HaEmek Medical Center, Israel•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 2

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262 · Urticaria Chronic

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 15, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment10

Start dateJul 2017

Last updatedSep 15, 2025

Condition

Urticaria Chronic

Locations shown

Emek Medical Center

Afula

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions